JP2005503394A5 - - Google Patents

Download PDF

Info

Publication number
JP2005503394A5
JP2005503394A5 JP2003523220A JP2003523220A JP2005503394A5 JP 2005503394 A5 JP2005503394 A5 JP 2005503394A5 JP 2003523220 A JP2003523220 A JP 2003523220A JP 2003523220 A JP2003523220 A JP 2003523220A JP 2005503394 A5 JP2005503394 A5 JP 2005503394A5
Authority
JP
Japan
Prior art keywords
rhinitis
disease
chronic
syndrome
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003523220A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005503394A (ja
Filing date
Publication date
Priority claimed from GBGB0117899.5A external-priority patent/GB0117899D0/en
Application filed filed Critical
Publication of JP2005503394A publication Critical patent/JP2005503394A/ja
Publication of JP2005503394A5 publication Critical patent/JP2005503394A5/ja
Pending legal-status Critical Current

Links

JP2003523220A 2001-07-23 2002-07-19 ケモカインレセプター活性の調節剤として有用なピペリジン誘導体 Pending JP2005503394A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0117899.5A GB0117899D0 (en) 2001-07-23 2001-07-23 Chemical compounds
PCT/SE2002/001401 WO2003018556A1 (en) 2001-07-23 2002-07-19 Piperidine derivatives useful as modulators of chemokine receptor activity

Publications (2)

Publication Number Publication Date
JP2005503394A JP2005503394A (ja) 2005-02-03
JP2005503394A5 true JP2005503394A5 (https=) 2006-01-12

Family

ID=9919003

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003523220A Pending JP2005503394A (ja) 2001-07-23 2002-07-19 ケモカインレセプター活性の調節剤として有用なピペリジン誘導体

Country Status (5)

Country Link
US (1) US7265227B2 (https=)
EP (1) EP1412330A1 (https=)
JP (1) JP2005503394A (https=)
GB (1) GB0117899D0 (https=)
WO (1) WO2003018556A1 (https=)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR033517A1 (es) * 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
SE0102809D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab Novel compounds
US6949590B2 (en) * 2002-01-10 2005-09-27 University Of Washington Hydrogels formed by non-covalent linkages
TW200303304A (en) * 2002-02-18 2003-09-01 Astrazeneca Ab Chemical compounds
SE0200843D0 (sv) * 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0200844D0 (sv) * 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0202838D0 (sv) * 2002-09-24 2002-09-24 Astrazeneca Ab Chemical compounds
MXPA05007485A (es) 2003-01-14 2006-01-30 Arena Pharm Inc Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
SE0300850D0 (sv) * 2003-03-25 2003-03-25 Astrazeneca Ab Chemical compounds
SE0300957D0 (sv) * 2003-04-01 2003-04-01 Astrazeneca Ab Chemical compounds
EP1638939A2 (en) * 2003-06-24 2006-03-29 Neurosearch A/S Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
SE0400208D0 (sv) 2004-02-02 2004-02-02 Astrazeneca Ab Chemical compounds
SE0400925D0 (sv) * 2004-04-06 2004-04-06 Astrazeneca Ab Chemical compounds
US20060167044A1 (en) * 2004-12-20 2006-07-27 Arnaiz Damian O Piperidine derivatives and their use as anti-inflammatory agents
DOP2006000010A (es) * 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
US20080200505A1 (en) * 2005-05-27 2008-08-21 Astrazeneca Ab Piperidines for the Treatment of Chemokine Mediated Diseases
TW200722419A (en) * 2005-05-27 2007-06-16 Astrazeneca Ab Chemical compounds
NZ565040A (en) 2005-06-28 2010-05-28 Sanofi Aventis Isoquinoline derivatives as inhibitors of RHO-kinase
WO2007011293A1 (en) * 2005-07-21 2007-01-25 Astrazeneca Ab Novel piperidine derivatives
JP5049970B2 (ja) 2005-07-26 2012-10-17 サノフイ Ｒｈｏ−キナーゼ阻害剤としてのシクロヘキシルアミンイソキノロン誘導体
KR101373535B1 (ko) 2005-07-26 2014-03-12 사노피 Ｒｈｏ-키나제 억제제로서의 피페리디닐-치환된 이소퀴놀론유도체
TW200812582A (en) * 2006-04-06 2008-03-16 Astrazeneca Ab Medicaments
RU2455302C2 (ru) 2006-12-27 2012-07-10 Санофи-Авентис ЗАМЕЩЕННЫЕ ИЗОХИНОЛИНОВЫЕ И ИЗОХИНОЛИНОНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Rho-КИНАЗЫ
KR20090092303A (ko) 2006-12-27 2009-08-31 사노피-아벤티스 사이클로알킬아민 치환된 이소퀴놀린 유도체
NZ577980A (en) 2006-12-27 2012-01-12 Sanofi Aventis Cycloalkylamine substituted isoquinolone derivatives
WO2008077555A2 (en) 2006-12-27 2008-07-03 Sanofi-Aventis Substituted isoquinolines and their use as rho-kinase inhibitors
RU2468011C2 (ru) 2006-12-27 2012-11-27 Санофи-Авентис Замещенные циклоалкиламином производные изохинолина и изохинолинона
EP2114920A1 (en) 2006-12-27 2009-11-11 Sanofi-Aventis Substituted isoquinoline and isoquinolinone derivatives
HRP20131040T1 (hr) 2008-06-24 2013-12-06 Sanofi Bi- i policikliäśki supstituirani izokinolin i derivati izokinolina kao inhibitori rho-kinaze
CN102131784B (zh) 2008-06-24 2014-08-27 赛诺菲-安万特 作为rho激酶抑制剂的取代的异喹啉和异喹啉酮
PT2313374E (pt) 2008-06-24 2013-11-29 Sanofi Sa Isoquinolinas e isoquinolinonas 6-substituídas
PH12013500547A1 (en) 2010-09-22 2013-06-10 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
MX386419B (es) 2015-01-06 2025-03-18 Arena Pharm Inc Metodos de condiciones de tratamiento relacionadas con el receptor s1p1.
EP3939965A1 (en) 2015-06-22 2022-01-19 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid for use in sipi receptor-associated disorders
MA47504A (fr) 2017-02-16 2019-12-25 Arena Pharm Inc Composés et méthodes de traitement de l'angiocholite biliaire primitive
ES2987794T3 (es) 2018-06-06 2024-11-18 Arena Pharm Inc Procedimientos de tratamiento de afecciones relacionadas con el receptor S1P1

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1243991A (en) 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
US4335127A (en) 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
DK159420C (da) 1983-03-09 1991-03-11 Ciba Geigy Ag N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater
FI853477L (fi) 1984-09-14 1986-03-15 Ciba Geigy Ag Foerfarande foer framstaellning av karbonylfoereningar.
CA1246074A (en) 1984-12-05 1988-12-06 Albertus H.M.T. Van Heertum Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
KR910006138B1 (ko) 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
EP0429341A3 (en) 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
JP2860689B2 (ja) 1990-03-14 1999-02-24 第一製薬株式会社 ピリミジン誘導体
FR2667317B1 (fr) 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
RU1824396C (ru) * 1991-02-28 1993-06-30 Харьковский фармацевтический институт Пиперидиламид 3,5-дибром-4-аминобензолсульфонилсукцинаминовой кислоты, про вл ющий нейролептическое и мочегонное действие
FR2675801A1 (fr) 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
US5143923B1 (en) 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
FR2676054B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
FR2724382B1 (fr) 1994-09-13 1996-10-18 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
ES2087038B1 (es) 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
EP0816362A4 (en) 1995-03-22 1998-07-08 Taisho Pharmaceutical Co Ltd Thiazole derivatives
JPH0940646A (ja) 1995-07-27 1997-02-10 Yamanouchi Pharmaceut Co Ltd ベンゼン縮合環誘導体又はその塩
JPH0977742A (ja) 1995-09-12 1997-03-25 Kyorin Pharmaceut Co Ltd 新規なベンズアミド誘導体
EP1021185A4 (en) 1996-05-16 2005-09-07 Synaptic Pharma Corp DIHYDROPYRIMIDINES AND THEIR JOBS
JP2000514049A (ja) 1996-06-27 2000-10-24 スミスクライン・ビーチャム・コーポレイション Ｉｌ―８受容体拮抗薬
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
WO1999004794A1 (en) 1997-07-25 1999-02-04 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6433165B1 (en) 1998-01-21 2002-08-13 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
WO1999038514A1 (en) 1998-02-02 1999-08-05 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
DE69921351T2 (de) 1998-11-17 2006-03-09 F. Hoffmann-La Roche Ag 4-Aroyl-Piperidin-CCR-3 Rezeptorantagonisten III
AU2056800A (en) 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company Heterocyclic piperidines as modulators of chemokine receptor activity
US6518286B1 (en) 1999-03-26 2003-02-11 Astrazeneca Ab Compounds
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
GB0013060D0 (en) 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) * 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
CA2422055A1 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
WO2002030899A1 (en) * 2000-10-09 2002-04-18 Novartis Ag N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3 receptor antagonists
SE0102809D0 (sv) 2001-08-22 2001-08-22 Astrazeneca Ab Novel compounds

Similar Documents

Publication Publication Date Title
JP2005503394A5 (https=)
JP2003507456A5 (https=)
JP2009506123A5 (https=)
JP2004520423A5 (https=)
JP2005521675A (ja) 喘息、ｃｏｐｄおよび他の疾患の治療におけるインドール−３−酢酸の使用
JP4669836B2 (ja) ピペリジニル−およびピペラジニル−アルキルカルバメート誘導体、その製造法および治療用途
US20050101612A1 (en) Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
DE69628334T2 (de) Chinolin derivate als nk3 antagoniste
JP2009528991A5 (https=)
ES2309539T3 (es) Compuestos de sulfonamida que modulan la actividad de los receptores de la quimioquina (ccr4).
WO2007053197A3 (en) Nanoparticulate acetaminophen formulations
EP1893212A2 (en) Multicyclic compounds and methods of their use
JP2011518207A (ja) 殺真菌剤ヒドロキシモイル−ヘテロ環誘導体
JP2009532417A5 (https=)
JP2004504301A5 (https=)
EP4008718B1 (en) Heteroarylamidopyridinol derivative and pharmaceutical composition comprising same as active ingredient for prevention or treatment of autoimmune disease
JP2010520893A5 (https=)
CA2403423A1 (en) Tri-aryl-substituted-ethane pde4 inhibitors
JP2017520571A5 (https=)
CN116916929A (zh) 吡咯并吡啶衍生物用于预防或治疗发炎疾病的新颖用途
ES2314445T3 (es) Nuevas n-pirazinil-fulfonamidas condensadas y su uso en el tratamiento de enfermedades mediadas por quimioquinas.
JP2013507377A5 (https=)
JP2008513352A5 (https=)
ES2578363B1 (es) Moduladores de los receptores A3 de adenosina
US20030203943A1 (en) Chemical complex comprising a pyridine carboxy derivative and an H2 histamine receptor antagonist